https://www.selleckchem.com/pr....oducts/pf-07321332.h
The degree of symptom improvement should also follow the degree of positive changes in neurocognitive function. Many patients do not respond early enough in the course of symptom evolution,2,3 and thus assessments of early neurocognitive mechanisms may guide treatment individualization during titration of doses and effects. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the etiologic agent of the current, world-wide coronavirus disease 2019 (COVID-19) pandemic. Angiotensin-converting enzyme 2 (ACE2) is the SARS-CoV-
Like
Comment
Share
